TruSight Oncology 500 (DNA)
Coming soon
A comprehensive 523-gene DNA assay for solid tumours, including copy-number analysis, tumour mutational burden and microsatellite instability.
| Clinical purpose | Comprehensive genomic profiling, including the biomarkers TMB and MSI that can be relevant to immunotherapy discussions. |
|---|---|
| Sample type | FFPE tumour tissue |
| Genes / regions covered | 523 genes for SNVs and indels, with copy-number analysis, TMB and MSI |
| Intended use | Comprehensive somatic profiling of solid tumours. |
| Approximate turnaround | Confirmed when you enquire |
| Report type | NGS report with quality metrics, variant evidence tiers, copy-number, TMB and MSI |
| Ordering requirements | Confirmed when you enquire |
| Price | Confirmed when you enquire |
Turnaround, price and sample requirements are confirmed when you enquire, so you never rely on an outdated figure. Whether this test is appropriate is a decision for the treating oncologist.